يعرض 1 - 20 نتائج من 345 نتيجة بحث عن '"Seymour, J. F"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Sharman, J. P., Ghia, P., Miranda, P., Bajwa, N., Rule, S., Shaw, B., Seymour, J. F.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38634256; info:eu-repo/semantics/altIdentifier/wos/WOS:001204507100001; numberofpages:5; journal:BRITISH JOURNAL OF HAEMATOLOGY; https://hdl.handle.net/20.500.11768/159977

  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: Andritsos L.A., Anghelina M., Neal J., Blachly J.S., Mathur P., Lele O., Dearden C., Iyengar S., Cross M., Zent C.S., Rogers K.A., Epperla N., Lozanski G., Oakes C.C., Kraut E., Ruppert A.S., Zhao Q., Bhat S.A., Forconi F., Banerji V., Handunnetti S., Tam C.S., Seymour J.F., Else M., Kreitman R.J., Saven A., Call T., Parikh S.A., Ravandi F., Johnston J.B., Tiacci E., Troussard X., Tallman M.S., Dietrich S., Tadmor T., Gozzetti A., Zinzani P.L., Robak T., Quest G., Demeter J., Rai K., Fernandez S.A., Grever M.

    مصطلحات موضوعية: HCL, outcome, registry

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36070610; info:eu-repo/semantics/altIdentifier/wos/WOS:000850971400001; volume:63; issue:13; firstpage:3021; lastpage:3031; numberofpages:11; journal:LEUKEMIA & LYMPHOMA; https://hdl.handle.net/11585/904793; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85137771499

  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Moradian, N., Ochs, H. D., Sedikies, C., Hamblin, M. R., Camargo, C. A., Martinez, J. A., Biamonte, J. D., Abdollahi, M., Torres, P. J., Nieto, J. J., Ogino, S., Seymour, J. F., Abraham, A., Cauda, V., Gupta, S., Ramakrishna, S., Sellke, F. W., Sorooshian, A., Wallace Hayes, A., Martinez-Urbistondo, M., Gupta, M., Azadbakht, L., Esmaillzadeh, A., Kelishadi, R., Esteghamati, A., Emam-Djomeh, Z., Majdzadeh, R., Palit, P., Badali, H., Rao, I., Saboury, A. A., Jagan Mohan Rao, L., Ahmadieh, H., Montazeri, A., Fadini, G. P., Pauly, D., Thomas, S., Moosavi-Movahed, A. A., Aghamohammadi, A., Behmanesh, M., Rahimi-Movaghar, V., Ghavami, S., Mehran, R., Uddin, L. Q., Von Herrath, M., Mobasher, B., Rezaei, N.

    Time: 21st Century

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000536766500001; volume:18; issue:1; firstpage:205; numberofpages:7; journal:JOURNAL OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/11583/2830777; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084963062; https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02364-2

  8. 8
    Academic Journal

    المساهمون: Grever M., Andritsos L., Banerji V., Barrientos J.C., Bhat S., Blachly J.S., Call T., Cross M., Dearden C., Demeter J., Dietrich S., Falini B., Forconi F., Gladstone D.E., Gozzetti A., Iyengar S., Johnston J.B., Juliusson G., Kraut E., Kreitman R.J., Lauria F., Lozanski G., Parikh S.A., Park J., Polliack A., Ravandi F., Robak T., Rogers K.A., Saven A., Seymour J.F., Tadmor T., Tallman M.S., Tam C.S., Tiacci E., Troussard X., Zent C., Zenz T., Zinzani P.L., Wormann B.

    وصف الملف: STAMPA

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000647074300001; volume:35; issue:7; firstpage:1864; lastpage:1872; numberofpages:9; journal:LEUKEMIA; https://hdl.handle.net/11585/867037; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105316132; https://www.nature.com/articles/s41375-021-01257-7

  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal

    المساهمون: Mato, A. R., Woyach, J. A., Brown, J. R., Ghia, P., Patel, K., Eyre, T. A., Munir, T., Lech-Maranda, E., Lamanna, N., Tam, C. S., Shah, N. N., Coombs, C. C., Ujjani, C. S., Fakhri, B., Cheah, C. Y., Patel, M. R., Alencar, A. J., Cohen, J. B., Gerson, J. N., Flinn, I. W., Ma, S., Jagadeesh, D., Rhodes, J. M., Hernandez-Ilizaliturri, F., Zinzani, P. L., Seymour, J. F., Balbas, M., Nair, B., Abada, P., Wang, C., Ruppert, A. S., Wang, D., Tsai, D. E., Wierda, W. G., Jurczak, W.

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:001058459600009; volume:389; issue:1; firstpage:33; lastpage:44; numberofpages:12; journal:THE NEW ENGLAND JOURNAL OF MEDICINE; https://hdl.handle.net/20.500.11768/159985

  12. 12
    Academic Journal

    المساهمون: Seymour, J. F., Byrd, J. C., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., O'Brien, S., Brown, J. R., Munir, T., Mato, A., Stilgenbauer, S., Bajwa, N., Miranda, P., Higgins, K., John, E., de Borja, M., Jurczak, W., Woyach, J. A.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37390310; info:eu-repo/semantics/altIdentifier/wos/WOS:001072450300001; volume:142; issue:8; firstpage:687; lastpage:699; numberofpages:13; journal:BLOOD; https://hdl.handle.net/20.500.11768/159988

  13. 13
    Academic Journal

    المساهمون: Cancer Research UK and UCL Cancer Trials Centre, University College Hospitals London, United Kingdom

    Relation: https://dx.doi.org/10.1097/hs9.0000000000000919; Townsend W, Hiddemann W, Buske C, Cartron G, Cunningham D, Dyer MJS, et al. Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study. HemaSphere. 2023 Jul;7(7):e919. PubMed PMID: 37404773. Pubmed Central PMCID: PMC10317485 Bristol-Myers Squibb, consultancy fees from F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb, Incyte, and Takeda, and travel and conference registration fees from F. Hoffmann-La Roche Ltd, Gilead Sciences, and Takeda. WH reports honoraria from F. Hoffmann-La Roche Ltd, Janssen, Gilead Sciences and Celgene; a consulting/advisory role for F. Hoffmann-La Roche Ltd, Janssen and Gilead Sciences; speakers’ bureau for F. Hoffmann-La Roche Ltd, Janssen and Gilead Sciences; research funding from F. Hoffmann-La Roche Ltd, Janssen and Bayer; and travel expenses/accommodation from F. Hoffmann-La Roche Ltd, Janssen and Gilead Sciences. CB reports honoraria and speakers’ bureau fees from, and a consulting/advisory role for F. Hoffmann-La Roche Ltd, Pfizer, Janssen, Hexal, Celltrion Healthcare, AbbVie, Novartis, Bayer, MorphoSys, Regeneron Pharmaceuticals, and BeiGene; and research funding from F. Hoffmann-La Roche Ltd, Janssen, Celltrion Healthcare, AbbVie, Bayer, Amgen, and MSD. GC reports a consultancy role for F. Hoffmann-La Roche Ltd and Celgene; and honoraria from Bristol-Myers Squibb, Sanofi, Janssen, Gilead Sciences, AbbVie, Takeda, F. Hoffmann-La Roche Ltd, and Celgene. DC acknowledges support and funding from the Royal Marsden NIHR Biomedical Research Center. MJSD reports research funding from F. Hoffmann-La Roche Ltd. JGG reports grants and personal fees from Celgene, AstraZeneca and Janssen; and personal fees from AbbVie, Gilead, Karyopharm, MorphoSys, Novartis, and T.G. Therapeutics.EP reports speakers’ fees from Gilead Sciences, advisory board fees from BeiGene, virtual conference attendance fees from Celgene, and travel and conference registration fees from Takeda. MD reports research funding from AbbVie, Bayer, Bristol-Myers Squibb/Celgene, Gilead Sciences/Kite, Janssen, and F. Hoffmann-La Roche Ltd; honoraria from Amgen, AstraZeneca, Gilead Sciences/Kite, Janssen, Lilly, Novartis, and F. Hoffmann-La Roche Ltd; and membership on an entity’s Board of Directors or advisory committees for AstraZeneca, BeiGene, Bristol-Myers Squibb/Celgene, Gilead Sciences/Kite, Janssen, Lilly/Loxo Oncology, Novartis, and F. Hoffmann-La Roche Ltd. JFS reports speakers’ bureau fees, advisory board fees, and research funding from AbbVie, advisory board fees from AstraZeneca, advisory board fees from BeiGene, advisory board fees and research funding from Bristol-Myers Squibb, scientific advisory board membership from Genor Biopharma, advisory board fees from Gilead, advisory board fees and research funding from Janssen, advisory board fees, speakers’ bureau fees, research funding and expert testimony fees from F. Hoffmann-La Roche Ltd, and advisory and expert testimony fees from TG Therapeutics. JT reports research funding from F. Hoffmann-La Roche Ltd, Celgene, Janssen, PCYC, and BeiGene. DK, TGN, and AK is employed by and has equity ownership interests in F. Hoffmann-La Roche Ltd. MH reports a consultancy/advisory role with Celgene, Gilead, and F. Hoffmann-La Roche Ltd and research funding from F. Hoffmann-La Roche Ltd. RM reports honoraria from F. Hoffmann-La Roche Ltd and Janssen. All the other authors have no conflicts of interest to disclose. Epub 2023/07/05. eng.; http://hdl.handle.net/10541/626436; Hemasphere

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المساهمون: National Health and Medical Research Council, Australian Government Medical Research, NHMRC Leadership Investigator, NHMRC Emerging Leadership Level 1 Investigator, THON, MRFF Award

    المصدر: Leukemia & Lymphoma ; volume 64, issue 9, page 1600-1604 ; ISSN 1042-8194 1029-2403